Exostoses, Multiple Hereditary - 7 Studies Found Completed : Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1)) : Multiple Myeloma : 2005-05-25 : Drug: vorinostat Vorinostat ca Completed : Vorinostat (MK-0683) Phase I Study in Cutaneous T-Cell Lymphoma (CTCL) Patients (MK-0683-089 EXT1) : Lymphoma : 2008-10-09 : Drug: vorinostat Parts I & II: Vorinostat (400 mg) Oral, daily (QD). Treatment period is 28 days per Completed : Safety and Tolerability Study for the Pneumococcal Conjugate Vaccine V114 Versus Prevnar™ (V114-001 EXT1)(COMPLETED) : Pneumococcal Vaccines : 2010-10-04 : Biological: Adults-Adjuvanted V114 Completed : Phase I Trial of Vorinostat (MK-0683, SAHA) in Combination With Decitabine in Patients With AML or MDS (MK-0683-055 EXT1) : Leukemia, Myelocytic, Acute Myelodysplastic Syndromes Myelodysplastic Syndromes : 2007-05-24 : Drug: vorinostat Other Names: Completed : An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2)) : Proteinuria : 2007-12-03 : Drug: Losartan Potassium Terminated : Dose Range Finding Study of MK-0941 in Patients With Type 2 Diabetes Mellitus on Insulin (MK-0941-007 AM3 EXT1 AM1)(TERMINATED) : Diabetes Mellitus, Type 2 : 2008-10-03 : Drug: MK-0941 MK-0941 tablets Completed : Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (0683-014 AM5, EXT1) : Mesothelioma Lung Cancer : 2005-08-05 : Drug: vorinostat Vorinostat th
